The perception of biological threats as marginal biosecurity issues had been prevalent for decades. States feared accidents, lab security issues, and disease monitoring. The premise of such a way of perceiving biological threats was that biological capability presupposed rare assets – money, knowledge, equipment – that remained rare and thus visible. This is no longer the case. The same developments that have led to genetic cures for cancer and sickle-cell anaemia have made p